The GB SARS-CoV-2 Real-Time RT-PCR is an in vitro nucleic acid amplification test (NAT) for the qualitative detection of novel coronavirus (SARS-CoV-2) in the respiratory tract specimens (i.e., sputum), serum or plasma, utilizing Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and TaqMan probe technology.

General Biologicals Corporation

Taipei City

General Biologicals Corporation startup from Taipei City, Taiwan is ranked 1500 out of 2449 worldwide and 14 from the 45 startups in Taiwan. See more information and additional rankings on the StartupBlink Global Ecosystem Map